133 related articles for article (PubMed ID: 35636468)
1. Neoadjuvant Superselective Intra-Arterial Cisplatin Chemoradiotherapy Combined With Surgery in Patients With T4 Squamous Cell Carcinoma of the Maxillary Sinus.
Ikeda M; Suzuki M; Matsuzuka T; Ishii S; Sato H; Murono S
J Oral Maxillofac Surg; 2022 Aug; 80(8):1445-1450. PubMed ID: 35636468
[TBL] [Abstract][Full Text] [Related]
2. Treatment outcomes of locally advanced squamous cell carcinoma of the maxillary sinus treated with chemoradioselection using superselective intra-arterial cisplatin and concomitant radiation: Implications for prognostic factors.
Ono T; Tanaka N; Umeno H; Chitose SI; Shin B; Aso T; On K; Hattori C; Etoh H; Kakuma T; Abe T
J Craniomaxillofac Surg; 2017 Dec; 45(12):2128-2134. PubMed ID: 29122485
[TBL] [Abstract][Full Text] [Related]
3. Clinical T staging is superior to fluorodeoxyglucose positron emission tomography for predicting local outcomes after intra-arterial infusion chemoradiotherapy for maxillary sinus squamous cell carcinoma.
Doi H; Fujiwara M; Kitajima K; Tanooka M; Terada T; Noguchi K; Ishikura R; Kamikonya N; Yamakado K
Nagoya J Med Sci; 2018 Nov; 80(4):541-550. PubMed ID: 30587868
[TBL] [Abstract][Full Text] [Related]
4. Laryngeal preservation in advanced piriform sinus squamous cell carcinomas using superselective intra-arterial chemoradiation therapy with three agents.
Furusaka T; Matsuda A; Tanaka A; Matsuda H; Ikeda M
Acta Otolaryngol; 2013 Mar; 133(3):318-26. PubMed ID: 23153059
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of intra-arterial docetaxel and nedaplatin infusion concomitant with radiotherapy for T4 maxillary sinus squamous cell carcinoma.
Heianna J; Makino W; Hirakawa H; Yamashita Y; Tomita H; Murayama S
Int J Oral Maxillofac Surg; 2022 Sep; 51(9):1123-1130. PubMed ID: 34955352
[TBL] [Abstract][Full Text] [Related]
6. Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer.
Homma A; Sakashita T; Yoshida D; Onimaru R; Tsuchiya K; Suzuki F; Yasuda K; Hatakeyama H; Furusawa J; Mizumachi T; Kano S; Inamura N; Taki S; Shirato H; Fukuda S
Br J Cancer; 2013 Dec; 109(12):2980-6. PubMed ID: 24196792
[TBL] [Abstract][Full Text] [Related]
7. Radiation with concomitant superselective intra-arterial cisplatin infusion for maxillary sinus squamous cell carcinoma.
Ebara T; Ando K; Eishima J; Suzuki M; Kawakami T; Horikoshi H; Tamaki Y
Jpn J Radiol; 2019 Jun; 37(6):494-499. PubMed ID: 30915648
[TBL] [Abstract][Full Text] [Related]
8. Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer.
Mitsudo K; Shigetomi T; Fujimoto Y; Nishiguchi H; Yamamoto N; Furue H; Ueda M; Itoh Y; Fuwa N; Tohnai I
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1428-35. PubMed ID: 20605340
[TBL] [Abstract][Full Text] [Related]
9. Salvage operations for patients with persistent or recurrent cancer of the maxillary sinus after superselective intra-arterial infusion of cisplatin with concurrent radiotherapy.
Sakashita T; Homma A; Hatakeyama H; Kano S; Mizumachi T; Furusawa J; Yoshida D; Fujima N; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Suzuki F; Fukuda S
Br J Oral Maxillofac Surg; 2014 Apr; 52(4):323-8. PubMed ID: 24582012
[TBL] [Abstract][Full Text] [Related]
10. Preliminary results of proton beam therapy combined with weekly cisplatin intra-arterial infusion via a superficial temporal artery for treatment of maxillary sinus carcinoma.
Nakamura T; Azami Y; Ono T; Yamaguchi H; Hayashi Y; Suzuki M; Hatayama Y; Tsukiyama I; Hareyama M; Kikuchi Y; Takayama K; Fuwa N
Jpn J Clin Oncol; 2016 Jan; 46(1):46-50. PubMed ID: 26538461
[TBL] [Abstract][Full Text] [Related]
11. Intra-arterial cisplatin and concomitant radiation therapy followed by surgery for advanced paranasal sinus cancer.
Samant S; Robbins KT; Vang M; Wan J; Robertson J
Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):948-55. PubMed ID: 15313865
[TBL] [Abstract][Full Text] [Related]
12. Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (Japan Clinical Oncology Group 1212): Dose-finding phase.
Homma A; Onimaru R; Matsuura K; Shinomiya H; Sakashita T; Shiga K; Tachibana H; Nakamura K; Mizusawa J; Kitahara H; Eba J; Fukuda H; Fujii M; Hayashi R
Head Neck; 2018 Mar; 40(3):475-484. PubMed ID: 29130565
[TBL] [Abstract][Full Text] [Related]
13. Management for squamous cell carcinoma of the nasal cavity and ethmoid sinus: A single institution experience.
Homma A; Nakamaru Y; Sakashita T; Onimaru R; Terasaka S; Tsuchiya K; Yoshida D; Yasuda K; Hatakeyama H; Furusawa J; Mizumachi T; Kano S; Shirato H; Fukuda S
Auris Nasus Larynx; 2015 Oct; 42(5):377-81. PubMed ID: 25748513
[TBL] [Abstract][Full Text] [Related]
14. Craniofacial Resection for T4 Maxillary Sinus Carcinoma: Managing Cases with Involvement of the Skull Base.
Nishio N; Fujimoto Y; Fujii M; Saito K; Hiramatsu M; Maruo T; Iwami K; Kamei Y; Yagi S; Takahashi M; Hayashi Y; Ando A; Nakashima T
Otolaryngol Head Neck Surg; 2015 Aug; 153(2):231-8. PubMed ID: 26044790
[TBL] [Abstract][Full Text] [Related]
15. An essential dose of cisplatin for super-selective intra-arterial infusion concomitant with radiotherapy in patient with maxillary squamous cell carcinoma.
Kanazawa Y; Shojaku H; Takakura H; Fujisaka M; Tachino H; Watanabe Y; Tomizawa G; Kawabe H; Shojaku H; Seto H; Otani K; Fukuoka J
Eur Arch Otorhinolaryngol; 2012 Aug; 269(8):1985-91. PubMed ID: 22146863
[TBL] [Abstract][Full Text] [Related]
16. A novel technique of arterial blood flow modification in intra-arterial chemoradiotherapy of maxillary sinus squamous cell carcinoma.
Kanno C; Masubuchi T; Fushimi C; Kitani Y; Niwa K; Takeishi E; Kaneko T; Yamazaki M; Hasegawa H; Kamata SE; Miura K; Tada Y
Oral Oncol; 2020 Jun; 109():104873. PubMed ID: 32604059
[TBL] [Abstract][Full Text] [Related]
17. Intra-arterial chemoradiation therapy with weekly low-dose cisplatin for squamous cell carcinoma of the maxillary sinus.
Kaneko T; Tada Y; Maruya S; Takeishi E; Miura K; Masubuchi T; Fushimi C; Hasegawa H; Kamata S
Int J Oral Maxillofac Surg; 2015 Jun; 44(6):697-704. PubMed ID: 25843537
[TBL] [Abstract][Full Text] [Related]
18. Results of multimodality therapy for squamous cell carcinoma of maxillary sinus.
Nibu K; Sugasawa M; Asai M; Ichimura K; Mochiki M; Terahara A; Kawahara N; Asato H
Cancer; 2002 Mar; 94(5):1476-82. PubMed ID: 11920504
[TBL] [Abstract][Full Text] [Related]
19. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
[No Abstract] [Full Text] [Related]
20. Superselective intra-arterial chemotherapy for laryngeal preservation in carcinoma of the anterior oropharyngeal wall.
Furusaka T; Matsuda A; Tanaka A; Matsuda H; Ikeda M
Acta Otolaryngol; 2013 Feb; 133(2):194-202. PubMed ID: 23106545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
